[The results of an open observational study on multimodal effects of the efficacy and safety of supplement neurouridine in patients with nonspecific low back pain (MULTINEURO-1)].

Autor:	Yakupov EZ; Scientific Research Medical Complex «Your Health», Kazan, Russia.; Kazan State Medical University, Kazan, Russia., Troshina YV; Scientific Research Medical Complex «Your Health», Kazan, Russia.; Kazan State Medical University, Kazan, Russia., Kashapova AO; Scientific Research Medical Complex «Your Health», Kazan, Russia., Nasrieva AM; Scientific Research Medical Complex «Your Health», Kazan, Russia., Chizh RS; Scientific Research Medical Complex «Your Health», Kazan, Russia.
Jazyk:	ruština
Zdroj:	Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2020; Vol. 120 (9), pp. 53-59.
DOI:	10.17116/jnevro202012009153
Abstrakt:	Objective: The article presents the results of the first observational study in the Russian Federation on the efficacy and safety of high doses of uridine monophosphate (150 mg) in combination with choline (the supplement neurouridine) in the treatment of patients with nonspecific low back pain. Material and Methods: The Visual Analogue scale (VAS), the painDETECT questionnaire (PD-Q), the Roland-Morris Low Back Pain and Disability Questionnaire, the Hospital Anxiety and Depression Scale (HADS) and the Pittsburgh Sleep Quality Index were used to assess the efficacy of neurouridin in 50 patients with lower back pain. Results and Conclusion: A conclusion was also made about a greater decrease in the intensity of pain in the main group than in the comparison group, a positive effect of treatment on a decrease in the severity of the neuropathic component of pain was not- ed according to the results of PD-Q, revealing signs of improved functional status according to the analysis of the Roland-Morris low back pain and disability questionnaire.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu